Due to the complexity of PD-L1 testing, the interpretation of the immunohistochemical PD-L1 examinations requires in-depth knowledge and appropriate training for the corresponding scores and cut-offs of the different tumor entities (Deutsche Akkreditierungsstelle (DAkkS) 2015). This evidence concerns the gene CD274 and neoplasm.